The most interesting finding in a new brain-imaging study is not that people with metabolic syndrome already had dementia.
They did not.
The researchers studied 223 cognitively unimpaired adults between 40 and 65 years old. Seventy-three met criteria for metabolic syndrome. Yet when the investigators examined resting-state brain activity with functional MRI, they detected a modest difference in one of the brain's best-studied large-scale networks: the default mode network, or DMN.
Adults with metabolic syndrome showed lower connectivity within the DMN than adults without metabolic syndrome. When the researchers examined the five metabolic-syndrome components separately, abdominal obesity and low HDL cholesterol were the two factors associated with lower DMN connectivity. Lower DMN connectivity, in turn, was associated with poorer performance on a verbal-fluency task.
The study was published September 9, 2026, in Frontiers in Aging Neuroscience. Read the full Gallagher et al. study.
That finding is intriguing because the participants were still in midlife and were considered cognitively unimpaired.
But it is equally important to say what the study does not show.
It does not prove that abdominal fat caused the brain-network difference. It does not prove that low HDL caused it. It does not show that participants were developing Alzheimer's disease. And a resting-state fMRI connectivity measure is not a direct recording of neurons firing.
What it does offer is a window into a much more useful prevention question:
Could cardiometabolic risk become visible in brain-network organization before obvious cognitive impairment appears?
Metabolic syndrome is a cluster—not a single disease
Metabolic syndrome is not one laboratory result and it is not another name for diabetes.
It describes a cluster of cardiometabolic risk factors that frequently occur together. Under the widely used harmonized definition, having at least three of five abnormal features can meet criteria for metabolic syndrome: increased waist circumference, elevated triglycerides, reduced HDL cholesterol, elevated blood pressure, and elevated fasting glucose. Read the international harmonized definition.
The exact waist-circumference threshold is not universal; appropriate cut points can differ across populations.
These factors matter because they can travel together with insulin resistance, vascular stress, inflammation, and increased risk for type 2 diabetes and cardiovascular disease.
But metabolic syndrome should not be interpreted as a diagnosis of dementia—or as proof that dementia is inevitable.
One reason this framework is useful is that it forces us to look beyond glucose alone.
Blood sugar matters. So do blood pressure, lipids, body-fat distribution, physical activity, sleep, diet, medications, and the broader vascular environment in which the brain operates.
What did the September 2026 study actually do?
The investigators analyzed 223 community-dwelling adults ages 40–65 who did not have diagnosed cognitive impairment. Of them, 73 had metabolic syndrome and 150 did not.
Participants underwent a cardiometabolic assessment that included waist circumference, fasting glucose, blood pressure, triglycerides, and HDL cholesterol. They also completed standard cognitive testing.
The brain-imaging component used resting-state functional MRI, or resting-state fMRI.
Rather than asking participants to perform a specific task in the scanner, researchers examined naturally occurring fluctuations in the blood-oxygen-level-dependent—or BOLD—signal while participants rested. They then asked how strongly activity patterns in different brain regions rose and fell together over time.
That coordinated pattern is what researchers call functional connectivity.
This distinction matters.
Functional connectivity does not mean researchers watched electrical signals jump directly from one neuron to another. BOLD fMRI is an indirect signal influenced by changes in blood oxygenation and hemodynamics.
And because this was a cross-sectional observational study, it can identify associations at one point in time. It cannot establish which factor came first.
What is the default mode network?
The default mode network is a group of brain regions whose activity tends to fluctuate together during rest and internally directed thought.
Core regions commonly include parts of the medial prefrontal cortex, posterior cingulate cortex/precuneus, and lateral parietal cortex.
The network participates in processes such as self-referential thinking, remembering past experiences, imagining future situations, and integrating internally generated information. Michael Raichle's landmark review describes the DMN as one of the brain's major intrinsic network systems. Read the DMN review.
Importantly, the DMN is not an "Alzheimer's network."
Changes in default-mode connectivity occur with normal aging, sleep, mood, vascular factors, metabolic disease, and multiple neurological conditions. DMN abnormalities have also been studied extensively in Alzheimer's disease, but detecting a connectivity difference does not diagnose Alzheimer's or predict an individual's future.
That nuance is particularly important for public-facing brain-health education.
A colorful brain scan can look definitive. The underlying measurement often is not.
What actually stood out?
The main analysis found a modest reduction in within-network DMN connectivity in the metabolic-syndrome group.
The investigators then examined each metabolic-syndrome component separately.
Two stood out:
Abdominal obesity was associated with lower DMN connectivity.
Low HDL cholesterol was associated with lower DMN connectivity and showed the larger component-level effect in this particular analysis.
The other three metabolic-syndrome components—triglycerides, blood pressure, and glucose—were not individually associated with DMN connectivity after the study's multiple-comparison adjustment.
That last sentence matters.
It would be incorrect to conclude that blood pressure or glucose do not matter for brain health. The study only tells us that, within this sample and this specific functional-connectivity analysis, those factors did not independently reach statistical significance.
In fact, the same research group previously examined structural brain aging in a closely related midlife cohort and found that metabolic syndrome was associated with evidence of structural brain-age vulnerability, with triglycerides emerging as an important component in that analysis. Read the 2025 structural brain-aging study.
Different brain measures can therefore highlight different pieces of cardiometabolic biology.
Why might abdominal obesity matter?
Body-fat distribution can tell us something that body weight alone cannot.
Subcutaneous fat—the fat stored under the skin—and visceral fat—the fat surrounding internal organs—are not metabolically identical. Greater central or visceral adiposity is frequently associated with insulin resistance, altered adipokine signaling, inflammation, dyslipidemia, and vascular risk.
That does not mean every person with a larger waist has the same biology, and waist circumference is only a clinical proxy.
But it helps explain why researchers increasingly care about where and how adipose tissue stores energy, not just total body weight.
Our recent article, How Fat Cells Store and Release Energy: New 2026 Research on Insulin, Leptin & Exercise, explores this directly: healthy adipose tissue is not simply a passive storage bag. It continually stores, releases, remodels, and sends hormonal signals to other organs.
A new Nature Reviews Neurology review published September 1, 2026, places obesity and brain health in a broader framework involving vascular dysfunction, inflammation, altered insulin signaling, hypothalamic dysfunction, and changes affecting the hippocampus, prefrontal cortex, and white matter. Read the 2026 Nature Reviews Neurology review.
Again, those pathways are plausible biological bridges.
They are not proof that the abdominal-obesity association in the Gallagher study was caused by any one of them.
What about HDL?
HDL is commonly called the "good cholesterol," but that shorthand can be misleading.
HDL particles participate in lipid transport and have relationships with vascular biology, inflammation, and other cardiometabolic processes. A low HDL concentration can function as a marker of an adverse metabolic environment, but simply raising the HDL number does not automatically guarantee improved outcomes.
So the new study should not be interpreted as:
low HDL directly damaged the default mode network.
A safer interpretation is:
In this midlife sample, meeting the low-HDL criterion was associated with lower DMN connectivity.
That finding may reflect HDL biology itself, other metabolic features that travel with low HDL, vascular factors, medication patterns, lifestyle, or combinations of these.
The observational design cannot separate those possibilities.
For a broader explanation of dietary fat and blood lipids without treating all fats as the same, see our Mindful Diabetes guide to fats.
Lower connectivity was associated with verbal fluency
The study also linked lower DMN connectivity with poorer verbal fluency.
Verbal-fluency tasks usually ask someone to generate words according to a rule—for example, naming as many items from a category as possible within a short period. Performance draws on language, retrieval, executive control, and processing efficiency.
The association in this study was statistically significant but modest.
This was not a group of people with diagnosed cognitive impairment suddenly failing memory tests.
That is precisely why the finding is interesting.
The researchers were looking for subtle brain-network and cognitive differences during a period of life when people may still feel completely cognitively normal.
The broader evidence is important—and not perfectly consistent
One study should never be treated as the entire literature.
Previous research has reported altered functional connectivity in people with metabolic syndrome or elevated cardiometabolic risk, including changes involving the DMN. A 2019 resting-state study reported abnormal DMN connectivity patterns in metabolic syndrome, while a 2023 Human Connectome Project–Aging analysis linked cardiovascular and metabolic health with functional connectivity across several brain systems. (Rashid et al., 2019; Rashid et al., 2023)
Other studies have not produced identical patterns. Some have reported increased rather than decreased connectivity in particular contexts.
That apparent disagreement is not unusual in network neuroscience.
Age, sex, medications, scan acquisition, motion correction, network definitions, statistical methods, disease duration, and the particular metabolic characteristics of a cohort can all affect the result.
Even the relationship between metabolic syndrome and future dementia varies across studies and dementia subtypes.
A 2025 meta-analysis of 21 studies involving more than 400,000 participants found metabolic syndrome associated with higher risks of all-cause dementia and cognitive impairment, but the pooled association with Alzheimer's disease specifically was not statistically significant. Read the meta-analysis.
Another large 2025 meta-analysis of longitudinal cohorts similarly found a modest association with all-cause dementia but not a statistically significant pooled association with Alzheimer's disease. Read the longitudinal meta-analysis.
So the message should not be:
metabolic syndrome equals Alzheimer's disease.
The evidence is far more heterogeneous than that.
Diabetes is not one metabolic phenotype either
A second new study published September 8, 2026 makes this point even more clearly.
Researchers used data from the U.S. Health and Retirement Study and applied unsupervised clustering to 2,292 adults with diabetes using eight variables: age at diabetes onset, BMI, HbA1c, total cholesterol, HDL cholesterol, systolic blood pressure, estimated glomerular filtration rate, and C-reactive protein.
They identified three diabetes subgroups:
Subgroup 1: higher BMI and elevated CRP.
Subgroup 2: later-onset diabetes, higher blood pressure, and lower eGFR.
Subgroup 3: earlier-onset diabetes, higher HbA1c, and higher cholesterol.
The incident-dementia analysis ultimately included 10,705 adults across normoglycemia, prediabetes, and the diabetes subgroups. Read the Zhao et al. study.
Compared with normoglycemia, only subgroup 3 had a statistically significant higher dementia risk in the primary analysis:
HR 1.43, 95% CI 1.15–1.77.
This does not mean everyone with those characteristics will develop dementia.
It also does not mean the other diabetes subgroups were "safe."
Cluster analyses are statistical descriptions of groups. Real people do not always fit cleanly into one box.
But the finding reinforces an increasingly important idea:
The label "type 2 diabetes" can hide meaningful biological heterogeneity.
Risk may depend on when diabetes develops, how glucose is controlled, body composition, kidney function, inflammatory state, blood pressure, lipids, genetics, medications, and many other factors.
What did the lifestyle analysis show?
The Zhao study also examined three lifestyle factors: never smoking, low-to-moderate alcohol consumption, and higher physical activity.
A favorable lifestyle score was associated with lower dementia risk among participants with normoglycemia, prediabetes, and diabetes subgroup 1, the group characterized by higher BMI and CRP.
In subgroup 1, the reported hazard ratio was 0.33 (95% CI 0.14–0.79) compared with an unfavorable lifestyle score.
That result is interesting, but it needs restraint.
The study was observational. It does not prove that these specific lifestyle behaviors caused the risk reduction. The confidence interval is wide. Diet was not included in the lifestyle score because the necessary dietary data were not available at the relevant HRS baseline waves.
And the absence of a statistically significant lifestyle association in the other clusters does not mean exercise, smoking avoidance, nutrition, blood-pressure management, or diabetes care are unimportant for those people.
It means this analysis did not establish the same statistical association in every subgroup.
Where does insulin resistance fit?
Insulin resistance is one plausible piece of the metabolism–brain connection, but it should not be turned into a one-sentence explanation for dementia.
The brain depends on a constant supply of energy and on healthy blood vessels, inflammatory regulation, lipid metabolism, hormonal signaling, and cellular communication.
Metabolic syndrome can involve abnormalities across several of those systems at once.
That is why current research increasingly considers overlapping pathways:
- vascular dysfunction and reduced cerebral perfusion;
- chronic low-grade inflammation;
- insulin resistance and altered nutrient handling;
- dyslipidemia;
- adipose-tissue endocrine signaling;
- blood-brain barrier and neurovascular-unit changes;
- sleep, physical activity, and other behavioral exposures.
The 2024 Lancet Commission on dementia prevention, intervention, and care included diabetes, hypertension, obesity, and high LDL cholesterol among potentially modifiable dementia risk factors across the life course. Read the Commission report.
That does not make dementia entirely preventable.
It does mean brain-health prevention extends beyond memory puzzles.
Can these brain-network differences be reversed?
The new fMRI study cannot answer that question.
It did not follow people over time to see whether DMN connectivity worsened, improved, or predicted later cognitive decline. It did not randomize participants to an intervention. And it did not test whether weight loss, exercise, lipid treatment, blood-pressure treatment, glucose management, or any other change altered the imaging result.
So we should resist a tempting but unsupported conclusion:
"Fix your metabolic syndrome and your DMN will recover."
We simply do not know that from this study.
What we do know is that many cardiometabolic risk factors are treatable and worth addressing for established reasons—reducing cardiovascular disease, preventing or managing diabetes, improving functional health, and supporting healthy aging.
The September study gives us an additional reason to take midlife seriously as a prevention window.
What can you actually do with this information?
The point of prevention science is not to make people frightened of an MRI scan they have never had.
It is to identify health factors that can be measured and discussed before a crisis.
Know your numbers—but do not reduce yourself to them
Useful markers can include blood pressure, HbA1c or fasting glucose when appropriate, triglycerides, HDL and LDL cholesterol, kidney function, weight trends, and waist circumference.
A number is a tool for a conversation, not a verdict.
Move regularly
Physical activity supports glucose regulation, cardiovascular function, blood pressure, sleep, fitness, and independence. Even walking is meaningful. Our Walking to Wellness guide is a practical place to start.
Build meals around overall quality
There is no single "brain food" that cancels cardiometabolic risk. Emphasizing vegetables, legumes, whole grains, nuts and seeds, fruit, fish and other lean proteins, and predominantly unsaturated fats can support broader metabolic and cardiovascular goals.
Our Free Health Guides include practical resources for building these habits without turning every meal into a test.
Treat blood pressure, glucose, and lipids as connected—not isolated
A person can have an acceptable glucose result and still have untreated hypertension or atherogenic lipids.
Likewise, improving one marker does not automatically normalize every other risk.
Work with your healthcare team to interpret the pattern.
Prioritize sleep and stress management
Sleep loss and chronic stress can affect appetite, blood pressure, glucose regulation, activity, and day-to-day decision-making.
They belong in metabolic-health conversations.
Use tools that make consistency easier
The science is increasingly sophisticated.
Daily prevention still comes down to behaviors that can be repeated.
Memovela was built around that idea: meals, movement, sleep, hydration, goals, and other wellness habits become more useful when they can be turned into sustainable routines rather than short bursts of perfection.
The message is not "your brain is already damaged"
This deserves to be said plainly.
The participants in the September 9 study were cognitively unimpaired.
The observed brain-network differences were modest.
Functional connectivity is an indirect imaging measure.
The study was cross-sectional.
The findings cannot tell an individual person whether they will develop cognitive impairment or dementia.
So the headline takeaway should not be fear.
It should be opportunity.
Midlife is a period when blood pressure, glucose, body-fat distribution, cholesterol, physical activity, sleep, and other cardiometabolic factors can already be measured—even when cognition seems completely normal.
The newest research suggests the brain may be part of that metabolic story earlier than obvious symptoms would tell us.
That makes prevention more relevant, not more frightening.
The 2026 takeaway
The September 2026 studies point toward a more individualized view of metabolic and brain health.
Metabolic syndrome was associated with subtle differences in default-mode-network connectivity in cognitively unimpaired adults ages 40–65.
Within that study, abdominal obesity and low HDL were the metabolic-syndrome components that stood out.
A separate U.S. cohort study showed that diabetes-related dementia risk was not uniform across metabolic phenotypes.
And a major new neurological review places obesity-related brain effects within a much broader network of vascular, metabolic, inflammatory, and hypothalamic biology.
None of this means metabolic syndrome inevitably becomes dementia.
None of it means an fMRI can tell you your future.
And none of it reduces Alzheimer's disease to "type 3 diabetes."
The more useful conclusion is:
Cardiometabolic health and brain health are connected, and midlife may give us an important opportunity to identify and address risk before obvious cognitive impairment appears.
That is the prevention window worth paying attention to.
Continue exploring
- How Fat Cells Store and Release Energy: New 2026 Research on Insulin, Leptin & Exercise
- Intermittent Fasting and Diabetes in 2026
- The Truth About Fats
- Walking to Wellness
- Free Mindful Diabetes Health Guides
- Memovela: Small Steps, Strong Habits
Educational information only. This article summarizes emerging research and is not a diagnosis, medical treatment plan, or prediction of individual dementia risk. Discuss personal cardiometabolic risk factors and treatment decisions with qualified healthcare professionals.
Scientific sources and further reading
- Gallagher I, McGill MB, Schnyer DM, Haley AP. Functional brain network connectivity patterns associated with midlife metabolic syndrome and cognitive vulnerabilities. Frontiers in Aging Neuroscience. 2026;18:1893842. doi:10.3389/fnagi.2026.1893842.
- Zhao X, Wang K, Tan Z, et al. Associations of diabetes subgroups and lifestyle with incident dementia: insights from unsupervised phenotype clustering analysis. Frontiers in Endocrinology. 2026;17:1938222. doi:10.3389/fendo.2026.1938222.
- McEntee CM, Savelieff MG, Noureldein MH, et al. Effects of obesity on brain health and cognition. Nature Reviews Neurology. 2026. doi:10.1038/s41582-026-01251-6.
- Gallagher I, McGill MB, Foret JT, et al. Hidden risk: Latent cognitive profiles and structural brain age reveal vulnerability in midlife metabolic syndrome. Journal of the International Neuropsychological Society. 2025. doi:10.1017/S1355617725101604.
- Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome. Circulation. 2009;120:1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644.
- Raichle ME. The brain's default mode network. Annual Review of Neuroscience. 2015;38:433–447. doi:10.1146/annurev-neuro-071013-014030.
- Rashid B, Dev S, Esterman M, et al. Aberrant patterns of default-mode network functional connectivity associated with metabolic syndrome. Brain and Behavior. 2019;9:e01333. doi:10.1002/brb3.1333.
- Rashid B, Glasser MF, Nichols T, et al. Cardiovascular and metabolic health is associated with functional brain connectivity in middle-aged and older adults. NeuroImage. 2023;276:120192. doi:10.1016/j.neuroimage.2023.120192.
- Qiu SD, Zhang DD, Ma LY, et al. Associations of metabolic syndrome with risks of dementia and cognitive impairment: a systematic review and meta-analysis. Journal of Alzheimer's Disease. 2025. doi:10.1177/13872877251326553.
- Metabolic syndrome and risk of incident all-cause dementia, Alzheimer's disease and vascular dementia: a systematic review and meta-analysis of longitudinal studies. Alzheimer's Research & Therapy. 2025. doi:10.1186/s13195-025-01825-4.
- Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet Standing Commission. The Lancet. 2024;404:572–628. doi:10.1016/S0140-6736(24)01296-0.
- Beyer F, Kharabian Masouleh S, Huntenburg JM, et al. Higher body mass index is associated with reduced posterior default mode connectivity in older adults. Human Brain Mapping. 2017;38:3502–3515. doi:10.1002/hbm.23605.